BIMIRALISIB
UNII 6Z3QHB00LB

Substance Identification & Data

This profile provides standardized clinical and technical data for Bimiralisib, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 6Z3QHB00LB.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1225037-39-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

6Z3QHB00LB

CAS Registry Number

1225037-39-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

BIMIRALISIB

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C17H20F3N7O2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

ADGGYDAFIHSYFI-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C111898

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

58507717

Unique identification number in the NCBI database of chemical substances.

INN ID

10519

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

FG-92

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

n1c(nc(nc1N2CCOCC2)-c3c(cc(nc3)N)C(F)(F)F)N4CCOCC4

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Bimiralisib. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.